U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07803562) titled 'Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp' on Aug. 29.
Brief Summary: The goal of this clinical trial is to learn if a low dose of dexamethasone can prevent cytokine release syndrome in participants treated with tebentafusp for advanced uveal melanoma. The main questions the study aims to answer are:
How many participants get cytokine release syndrome? How severe is the cytokine release syndrome? What other side effects happen due to dexamethasone and/or tebentafusp?
Participants will be treated with tebentafusp per standard practices. For this study, participants will recei...